Treatment-resistant schizophrenia: clinical experience with new antipsychotics
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6 (3) , 21-25
- https://doi.org/10.1016/0924-977x(96)00012-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1996
- Neuroleptic Withdrawal in Schizophrenic PatientsArchives of General Psychiatry, 1995
- RisperidoneDrugs, 1994
- Domains of PsychopathologyJournal of Nervous & Mental Disease, 1994
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Clozapine‐related seizuresNeurology, 1991
- New Antipsychotics: Classification, Efficacy, and Adverse EffectsSchizophrenia Bulletin, 1991
- Important Issues in the Drug Treatment of SchizophreniaSchizophrenia Bulletin, 1980
- Agranulocytosis in patients treated with clozapineActa Psychiatrica Scandinavica, 1977